NO20074101L - Isolering av CCI-779 fra morvaesker - Google Patents

Isolering av CCI-779 fra morvaesker

Info

Publication number
NO20074101L
NO20074101L NO20074101A NO20074101A NO20074101L NO 20074101 L NO20074101 L NO 20074101L NO 20074101 A NO20074101 A NO 20074101A NO 20074101 A NO20074101 A NO 20074101A NO 20074101 L NO20074101 L NO 20074101L
Authority
NO
Norway
Prior art keywords
cci
isolation
mother liquids
mother
liquids
Prior art date
Application number
NO20074101A
Other languages
English (en)
Norwegian (no)
Inventor
Bogdan Kazimierz Wilk
Warren Chew
Chia-Cheng Shaw
Genevieve Fortier
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20074101L publication Critical patent/NO20074101L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treating Waste Gases (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
NO20074101A 2005-03-02 2007-08-08 Isolering av CCI-779 fra morvaesker NO20074101L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65753405P 2005-03-02 2005-03-02
PCT/US2006/006207 WO2006093743A1 (en) 2005-03-02 2006-02-22 Recovery of cci-779 from mother liquors

Publications (1)

Publication Number Publication Date
NO20074101L true NO20074101L (no) 2007-09-26

Family

ID=36602445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074101A NO20074101L (no) 2005-03-02 2007-08-08 Isolering av CCI-779 fra morvaesker

Country Status (21)

Country Link
US (1) US7288647B2 (es)
EP (1) EP1853611A1 (es)
JP (1) JP2008531685A (es)
KR (1) KR20070107072A (es)
CN (1) CN101133066A (es)
AR (1) AR053151A1 (es)
AU (1) AU2006218916A1 (es)
BR (1) BRPI0607390A2 (es)
CA (1) CA2599580A1 (es)
CR (1) CR9325A (es)
GT (1) GT200600095A (es)
IL (1) IL185078A0 (es)
MX (1) MX2007010715A (es)
MY (1) MY138328A (es)
NI (1) NI200700226A (es)
NO (1) NO20074101L (es)
PE (1) PE20061293A1 (es)
RU (1) RU2007130407A (es)
TW (1) TW200643023A (es)
WO (1) WO2006093743A1 (es)
ZA (1) ZA200707526B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
CN101321770A (zh) * 2005-12-07 2008-12-10 惠氏公司 由雷帕霉素42-酯硼酸酯制备雷帕霉素42-酯的可放大方法
AR058282A1 (es) * 2005-12-07 2008-01-30 Wyeth Corp Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
US20070203169A1 (en) * 2006-02-28 2007-08-30 Zhao Jonathon Z Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993749A (en) 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
EP1646635A1 (en) * 2003-07-16 2006-04-19 Wyeth Cci-779 isomer c
JP4227649B2 (ja) 2003-08-07 2009-02-18 ワイス Ｃｃｉ−７７９の位置選択的合成
US20060015840A1 (en) * 2004-03-31 2006-01-19 Wendall Marvel Parameter-based software development, distribution, and disaster recovery

Also Published As

Publication number Publication date
PE20061293A1 (es) 2006-12-22
AR053151A1 (es) 2007-04-25
NI200700226A (es) 2008-07-03
RU2007130407A (ru) 2009-04-10
US20060199253A1 (en) 2006-09-07
BRPI0607390A2 (pt) 2017-08-22
MY138328A (en) 2009-05-29
EP1853611A1 (en) 2007-11-14
CN101133066A (zh) 2008-02-27
IL185078A0 (en) 2007-12-03
CA2599580A1 (en) 2006-09-08
GT200600095A (es) 2006-10-25
CR9325A (es) 2008-01-21
MX2007010715A (es) 2007-10-12
US7288647B2 (en) 2007-10-30
JP2008531685A (ja) 2008-08-14
KR20070107072A (ko) 2007-11-06
AU2006218916A1 (en) 2006-09-08
WO2006093743A1 (en) 2006-09-08
TW200643023A (en) 2006-12-16
ZA200707526B (en) 2010-02-24

Similar Documents

Publication Publication Date Title
DK2292607T3 (da) Fremgangsmåde til syntese af organiske forbindelser
CL2008000322A1 (es) Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
DK1795576T3 (da) Fremgangsmåde til fremstilling af carbonhydrider
DK1774878T3 (da) Fremgangsmåde til fremstilling af en drikkevare fra en kapsel
TWI318622B (en) Process for the manufacture of dichloropropanol by chlorination of glycerol
HUS1200023I1 (hu) Eljárás vakcinák elõállítására
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
IL185110A0 (en) Processes for the production of organometallic compounds
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
WO2008151170A3 (en) Process for the synthesis of ramelteon and its intermediates
NO346368B1 (no) En fremgangsmåte for konsentrasjon av alfa-mannosidase.
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
DK2082054T3 (da) Fremgangsmåde til forbedring af udbyttet af celluloseomdannelsesprocesser
CL2007003875A1 (es) Compuestos derivados de amidas del acido 3-amino tetrahidrofurano-3-carboxilico; procedimiento de preparacion de dichos compuestos.
NO20053687D0 (no) Crystallisation Process.
FR2912403B1 (fr) Procede de fabrication du chlorure de methylene.
NO20074101L (no) Isolering av CCI-779 fra morvaesker
EP1752464A4 (en) PROCESS FOR THE PREPARATION OF TIMOSAPONIN B II
DK1843977T3 (da) Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
EG25292A (en) Process for the production of anilines.
ZA200709621B (en) Process for the synthesis of organic compounds
EG25285A (en) Process for the removal of oxygenates from a gaseous stream.
IL184221A0 (en) Process for the manufacture of taurine
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
WO2006122020A3 (en) Process for production of 4-biphenylyazetidin-2-ones

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application